Get Vincent T. DeVita essential facts below. View Videos or join the Vincent T. DeVita discussion. Add Vincent T. DeVita to your PopFlock.com topic list for future reference or share this resource on social media.
The Pier Luigi Nervi International Award for Cancer Research that DeVita received in 1985
Vincent Theodore DeVita Jr. (born March 7, 1935) is the Amy and Joseph Perella Professor of Medicine at Yale Cancer Center, and a Professor of Epidemiology and Public Health. He directed the Yale Cancer Center from 1993 to 2003. He has been president of the American Cancer Society (2012-2013). He is internationally recognized as a pioneer in the field of oncology for his work on combination-chemotherapy treatments.
DeVita joined the National Cancer Institute (NCI) in 1963 as a clinical fellow, working with Emil "Tom" Frei, Emil J. Freireich and others. He returned as a senior investigator in 1966 after completing his training at Yale-New Haven Medical Center in 1965.
At NCI, DeVita held the following posts: Senior Investigator in the Solid Tumor Service, Head of the Solid Tumor Service, Chief of the Medicine Branch, Director of the Division of Cancer Treatment and Clinical Director of NCI (as of 1975).
While at NCI, he helped to develop MOPP, a four-drug combination that was the first successful combination chemotherapy program. At the time, many oncologists believed such an approach was too toxic and would do more harm than good. MOPP was used to treat Hodgkin's disease and diffuse large cell lymphomas, reducing the likelihood of dying from Hodgkin's disease from nearly 100% to around 30%. DeVita's results, presented in 1965 and 1970 were initially viewed with considerable disbelief.
By demonstrating that a combination-chemotherapy regimen could be successful, DeVita established the basis for further combination therapies, which became a mainstay of cancer treatment.
In addition, in collaboration with George Canellos, DeVita developed the combination chemotherapy CMF, which still remains a useful therapy for breast cancer.:165
In 1993 he returned to Yale, where he became Director of Yale Cancer Center, serving from 1993 to 2003. In 2004, he was named as the Amy and Joseph Perella Professor of Medicine at Yale University, a position to be renamed the Vincent T. DeVita Professor of Medicine after his tenure. He is currently the chair of the Yale Cancer Center advisory board and is professor of internal medicine and of epidemiology and public health at Yale's medical school.
From 2012-2013, DeVita served as president of the board of directors of the American Cancer Society.
DeVita currently serves on the editorial boards of numerous scientific journals and has authored over 450 scientific articles. He is a co-editor of the textbook Cancer: Principles and Practice of Oncology, in its 10th edition, and serves as the co-editor-in-chief of The Cancer Journal.
He is also the co-author, with his daughter Elizabeth DeVita-Raeburn, of the autobiographical book, The Death of Cancer: After Fifty Years on the Front Lines of Medicine, a Pioneering Oncologist Reveals Why the War on Cancer Is Winnable--and How We Can Get There.
Vincent DeVita married Mary Kay Bush, with whom he has had two children, Ted and Elizabeth. Vincent DeVita diagnosed his son Ted as a child with aplastic anemia. Ted thereafter was placed in a sterile environment for his safety, and died in 1980 at the age of 17.
^ abMukherjee, Siddhartha (2011). The emperor of all maladies : a biography of cancer (1st Scribner ed.). New York: Scribner. ISBN978-1439170915.
^Canellos, George P.; DeVita, Vincent T.; Gold, G. Lennard; Chabner, Bruce A.; Schein, Philip S.; Young, Robert C. (1 April 1976). "Combination Chemotherapy for Advanced Breast Cancer: Response and Effect on Survival". Annals of Internal Medicine. 84 (4): 389-92. doi:10.7326/0003-4819-84-4-389. PMID1259283.